Urinary excretion of glycosaminoglycans and albumin in experimental diabetes mellitus

• Autor(a) principal: Cadaval, Augusto de Miranda [UNIFESP]
• Data de Publicação: 2000
• Outros Autores: Kohlman, Oswaldo [UNIFESP], Michelacci, Yara Maria [UNIFESP]
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNIFESP
• dARK ID: ark:/48912/0013000006rtj
• DOI: 10.1093/glycob/10.2.185
• Texto Completo: http://dx.doi.org/10.1093/glycob/10.2.185; http://repositorio.unifesp.br/handle/11600/26239
• topic: albuminuria; diabetes mellitus; glycosaminoglycan; kidney; urine

Diabetes mellitus was induced in one group of rats by a single injection of streptozotocin. the glycemia, the body weight, and the blood systolic pressure were measured every week, and the 24 h urine volume and urinary excretions of creatinine, albumin and glycosaminoglycans were measured every 2 weeks, At the end of the experiment (12 weeks) the weight and the glycosaminoglycan composition of the kidneys were determined. All the diabetic animals were hyperglycemic, hypertense, and did not gain weight during all the experimental period. Albuminuria appeared from the second week on. Rat urine was shown to contain heparan sulfate, chondroitin sulfate, and dermatan sulfate, and the glycosaminoglycan excretion decreased in all diabetic animals. the onset of the change in glycosaminoglycan excretion rate was a very early event, appearing in the second week after diabetes induction. the main glycosaminoglycan found in normal rat kidney was heparan sulfate and, in contrast to the urine, the total kidney glycosaminoglycans increased in diabetic kidney, due to chondroitin sulfate and dermatan sulfate accumulation. the heparan sulfate concentration (per tissue dry weight) did not change. Our results suggest that quantification of urinary glycosaminoglycans may be a useful tool for the early diagnosis of diabetic nephropathy.